Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

Abstract Background The efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on the evaluation of olanzapine’s efficacy and safety at a low dose of 5 mg among patients treated with carboplatin regimens. Therefore,...

Full description

Bibliographic Details
Published in:	BMC Cancer
Main Authors:	Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, Hitoshi Kawazoe, Kazuki Tanaka, Yukiyoshi Fujita, Masakazu Abe, Hisao Imai, Masato Karayama, Yoh Hayasaki, Chiemi Hirose, Takafumi Suda, Kazuto Nakamura, Akio Suzuki, Yasushi Ohno, Ken-ichirou Morishige, Naoki Inui
Format:	Article
Language:	English
Published:	BMC 2021-07-01
Subjects:	Antiemetics Carboplatin Nausea Olanzapine Vomiting
Online Access:	https://doi.org/10.1186/s12885-021-08572-3

Similar Items

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials
by: Suguru Kojima, et al.
Published: (2025-10-01)

The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature
by: G. Saudemont, et al.
Published: (2020-04-01)

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
by: Ghufran salah ahmed, et al.
Published: (2023-05-01)

Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study
by: Tomohiko Kimura, et al.
Published: (2024-03-01)

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children
by: So Rae Lee, et al.
Published: (2020-09-01)

Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Kyoko Oura, et al.
Published: (2025-05-01)

Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer
by: Yuko Watanabe, et al.
Published: (2021-06-01)

The effect and safety of olanzapine on nausea and vomiting in children receiving moderately emetogenic chemotherapy
by: Aziz Eghbali, et al.
Published: (2023-01-01)

Clinical Observation of Olanzapine in Treatment of Nausea and Vomiting Caused by Opioid Analgesics
by: LI Daojun, et al.
Published: (2018-05-01)

Olanzapine-induced Psoriasis
by: Ashish Hanmantrao Chepure, et al.
Published: (2017-01-01)

Olanzapine versus haloperidol: Which can control stuttering better?
by: Vahid Shaygannejad, et al.
Published: (2013-01-01)

Report of a Rare Case of Olanzapine and Risperidone Induced Hypomania
by: AR Zahiroddin, et al.
Published: (2006-07-01)

An overview of the latest ASCO recommendations about antiemetic prophylaxis for treatment-related nausea and vomiting
by: Mehmet Akif Öztürk
Published: (2017-12-01)

Olanzapine induced hyponatremia and rhabdomyolysis
by: N'joumi Younes, et al.
Published: (2023-02-01)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
by: S. Bise, et al.
Published: (2022-06-01)

Olanzapine-induced hiccups： a case report
by: Sun Zhenxiao, et al.
Published: (2021-04-01)

Effect of olanzapine treatment on INR of a patient receiving warfarin therapy
by: Derya Arslan, et al.
Published: (2016-06-01)

Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
by: Avinash Pandey, et al.
Published: (2014-01-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Olanzapine-induced Pancytopenia: Case Report
by: A Prajnashree, et al.
Published: (2024-11-01)

Safety profile and adverse effects of use of olanzapine in pregnancy: A report of two cases
by: Manoj K Sahoo, et al.
Published: (2022-01-01)

Cerrahi Müdahale Gerektiren Olanzapin İlişkili Paralitik İleus Olgusu
by: Halil İbrahim Taşçı
Published: (2019-03-01)

A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
by: Ivy O. Poon, et al.
Published: (2024-02-01)

Rare occurence of amennorrhea associated with olanzapine : a case report
by: A. Khivsara, et al.
Published: (2022-06-01)

Emphysematous pancreatitis predisposed by Olanzapine
by: Sukhen Samanta, et al.
Published: (2014-01-01)

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
by: Shimokawa M, et al.
Published: (2022-09-01)

Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial
by: Hirotoshi Iihara, et al.
Published: (2019-07-01)

Olanzapine-induced Priapism in a Child with Asperger’s Syndrome
by: Hasan Bozkurt, et al.
Published: (2017-02-01)

Is there association of olanzapine and pulmonary embolism: A case report
by: Lumin Wang, et al.
Published: (2022-06-01)

Successful Chemotherapy with Carboplatin and S-1 for Thymic Carcinoma: A Case Report
by: Satoshi Igawa, et al.
Published: (2013-10-01)

Carboplatin hypersensitivity in children with glial tumors: a report of two cases
by: Tugce Kazgan, et al.
Published: (2016-12-01)

Reduction Behavior of Olanzapine and Its Differential Pulse Voltammetric Determination in Human Urine and Pharmaceuticals
by: Sultan Yağmur
Published: (2020-12-01)

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug
by: Xiao-Ling Zhang, et al.
Published: (2022-10-01)

Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
by: Sanya Sharma, et al.
Published: (2023-10-01)

Hypersensitivity and cross-reactivity to cisplatin and carboplatin
by: Gholamreza Faridaalaee, et al.
Published: (2016-07-01)

Olanzapine and its use for methamphetamine-induced psychosis
by: S. Nazir, et al.
Published: (2022-06-01)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
by: Seema M. Patel, PharmD, BCPP, et al.
Published: (2021-01-01)

Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-09-01)

Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-07-01)

Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
by: Sevgi Ayhan, et al.
Published: (2023-09-01)